LABT news

Latest 1 stories · newest Nov 10, 2026

LABT

Lakewood-Amedex completes $1.27M Series C Preferred Stock redemption

Lakewood-Amedex Biotherapeutics Inc. redeemed all outstanding Series C Convertible Preferred Stock for $1.27M from cash on hand, eliminating potential dilution and associated financing restrictions prior to testing.

Restructuring Nov 10, 2026 sentiment +0.80 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same LABT feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/LABT/newsSTART FREE